Morningstar® Stock Report™

Merck & Co Inc MRK

Gewinnmarge (% des Umsatzes)
20192020202120222023
Ertrag100,00%100,00%100,00%100,00%100,00%
Betriebskosten30,13%32,26%27,98%29,37%26,83%
Bruttogewinn69,87%67,74%72,02%70,63%73,17%
Vertriebsgemeinkosten22,66%21,81%19,78%16,94%17,47%
Forschung und Entwicklung21,08%28,25%25,14%22,85%50,79%
Umsatzrendite26,13%17,68%27,10%30,84%4,91%
Net Int, Inc and Other50,61%35,99%55,60%58,58%8,06%
EBIT Marge24,47%18,32%28,50%27,74%3,14%
Ertragskraft
20192020202120222023
Steuersatz3,60%3,56%3,12%3,24%2,52%
Nettomarge21,01%14,72%26,79%24,49%0,61%
Gesamtkapitalrendite11,798,0313,2313,520,34
Financial Leverage3,263,622,772,372,84
Eigenkapitalsrendite37,4227,5941,1034,500,87